Keywords
However, physicians working in primary care are familiar with ICD-10 criteria. Therefore, the aim of the present study was to examine the feasibility of the validation of an ICD-10-derived symptom scale for depression. Methods: For this preliminary trial we generated a symptom scale derived 1:1 from the diagnostic criteria for depression given in the ICD-10 with 10 items. The Hamilton Rating Scale for Depression (HAMD-17) was used as reference in a population of 226 outpatients suffering from depressive symptoms. Correlation between scales as well as sensitivity and specificity of the ICD-10 scale were calculated. Results: The generated ICD-10 symptom scale for depression could be analyzed in 219 patients and showed a significant and strong correlation with the HAMD-17 (p < 0.0001; = 0.75). The best tradeoffs between specificity and sensitivity of the ICD-10 score were found at 10 points for the lower and 14 points for the upper cut-off. Overall sensitivity and specificity was 76.7 and 88.6%. Almost two thirds (i.e. 65.3%) of the patients were correctly classified by the ICD-10 scale.
Conclusion:
The ICD-10 symptom scale examined in the current population was found to have fair correlation with the HAMD-17 as well as, in face of the limited variance of the patients' condition, acceptable sensitivity and specificity. Therefore, this preliminary study showed that the ICD-10-derived symptom scale seems appropriate to be investigated in a thorough validation trial. Manual for Mental Disorders DSM-III-R [17] or the Symptom Checklist SCL-90 [7] .
Schlüsselwörter
Therefore, it was of particular interest for us to examine the feasibility in a population of outpatients with depressive syndrome, whether and if so to which extent the symptoms listed in the ICD-10 correlate with a validated instrument to corroborate the rationale for thorough validation trial. The data presented herein are preliminary and investigate the correlation with another validated scale widely used in patients with depressive symptoms, the Hamilton Rating Scale for Depression in its 17-item version (HAMD-17). The results of the open trial on efficacy and safety of the intervention with a drug from St. John's wort in a community-based outpatient setting (n = 1,541) in which the ICD-10-derived scale had also been tested have been published elsewhere [18] .
Methods
In a subpopulation of an open study [18] , 40 investigators (i.e. GPs, neurologists, psychiatrists) used HAMD-17 next to the constructed ICD-10 scale to evaluate the feasibility for validation. Patients had to be ≥ 18 years old, understand German sufficiently, and give consent to participate.
The reference scale, the HAMD-17, is a multiple choice questionnaire with 17 questions for detecting symptoms of major depression such as depressed mood, guilt, suicide agitation, loss of weight etc. The clinician rates the responses to each question by interviewing the patient and observing the symptoms. Depending on the questions 3-5 possible answers are available to rate the severity of the depression. Interpretation of the total score varies according to different recommendations (e.g. 0-7 = normal; 8-13 = mild depression; 14-18 = moderate depression; 19-22 = severe depression and ≥23 = very severe depression).
The test-scale, the ICD-10 symptom scale for depression (ICD-10-D) was derived 1:1 from the diagnostic criteria for depression given in the ICD-10 chapter of affective disorders (depressive syndrome, F32-F34) [19] to generate a symptom scale. The 10 criteria employed for construction were lowering of mood, loss of interest, lack of energy, reduction
Introduction
The prevalence of depression in clinics and in general practices is around 10-25% for women, 5-12% for men and 75-80% for patients experiencing recurrent depression [1] [2] [3] . Consequently it is most likely that general practitioners (GPs) and specialists face patients with depressive symptoms among their weekly outpatients.
Yet, GPs are said to fail to diagnose 50% of depressed outpatients [4] . Even in research the screening for depression with valid instruments has demonstrated only limited benefit [5] . In daily practice one might doubt if a lack of knowledge or availability of numerous valid instruments [6] [7] [8] [9] [10] [11] , widely known among specialists, is the problem or rather the lack of time needed for the correct administration of instruments in the face of limited resources. Yet, one would have to admit that even among psychiatrists the discussion which questionnaire should be used remains lively discussed [12, 13] .
Nevertheless, patients, physicians, and health insurances are interested in quality of medical care, although from different viewpoints. Next to the effort to improve therapy according to evidence-based medicine (EbM), the evaluation of the efficacy of treatment is important for patients, physicians and increasingly also for health insurances. Notwithstanding, the first impression of the physician during clinical examination is one of the earliest diagnostic criteria to find out the medical state of the patient.
Unfortunately, the increasing economic pressure has entered the medical system as well, and although this rises many ethical questions [14] , time for the patient is often short and the administration of time-consuming validated rating scales seems often hardly possible [7, 12] . Yet, for classification of depressive symptoms in daily practice and for communication between physicians the ICD-10 is a worldwide used system [15] . Within the ICD-10 the operational diagnostic criteria for depressive syndromes are a special case as they cover criteria mentioned in existing validated questionnaires. They have been applied in evalutating outpatients, showed good concordance in diagnosis between GPs as well as psychiatrists [16] , and correlated well with the Diagnostic and Statistical
Symptoms
Rating, % For validation of the ICD-10 scale n = 219 patients could be analyzed. The ICD-10 scale for depression showed a significant and strong correlation with the HAMD-17 (p < 0.0001; = 0.75; fig. 1 ). Yet, was weaker in the sub-scores HAMD 1-7 including the depression triad (depressed mood, guilt, suicidal thought) [10] and 8-17 including symptoms with an often co-morbid impact (e.g. anxiety, somatic, hypochondriac sympTo differentiate the depressive symptoms of the patients, we examined other common psychiatric co-morbidities often related with depression (i.e. somatic symptoms of anxiety/depression, somatoform disorder, and anxiety).
Statistics
Statistical analysis was performed with WinSTAT Version 2001.1 for Windows (SPSS-validated). The continuous data are presented as means, standard deviations (SD); additionally medians as well as 95% confidence intervals and numbers of patients were calculated. Categorical data are presented using counts and percentages rounded to one decimal place. All p-values are 2-tailed, and p < 0.05 was considered statistically significant.
Validity of the ICD-10 scale was examined by calculating the correlation of the total score with the HAMD-17. For the correlation coefficient ranging from -1 to 1, correlations between 0.5-1.0 were interpreted as strong. For the co-morbidities was also calculated.
Sensitivity and specificity of a quantitative test depend on the cut-off value above or below which the test is positive. In general, the higher the sensitivity, the lower the specificity, and vice versa. The testing of sensitivity and specificity of increasing lower and upper cut-offs of the ICD-10 scores versus the HAMD-17 as reference were calculated manually, and the best trade-offs between specificity and sensitivity were chosen as cut-offs. The best trade-off between specificity and sensitivity was identified as the one yielding the highest value when calculating the product of specificity and sensitivity. Graphically, plotting specificity and sensitivity by increasing cut-offs, this point corresponds to the intersection of the 2 curves. For the current analysis we have employed the recommended cut-offs for the HAMD-17: lower limit = 8 and upper limit = 18 [12, 13] .
Results
Of the 226 patients recruited (173 females, 46 males, 7 no data), 219 provided full sets of data and could be analyzed. In median their age was 49 years (mean ± SD 50.52 ± 14.70 years) and they had a median duration of symptoms of 3 Regarding the lower limit (i.e. distinguishing between depression and normal) sensitivity was at 0.86 and specificity at 0.89. However, the relevance of this assertion is limited by the small number of patients in the normal range in both the HAMD-17 and the ICD-10 scale (table 5). For the upper limit (i.e. distinguishing between mild to moderate depression and severe/very severe depression) sensitivity was at 0.80 and specificity at 0.77.
Discussion
In daily medical practice of the medical systems in the Northern hemisphere, physicians are confronted with different aspects of EbM in order to contribute to best possible clinical practice which primarily ought to serve the patient and secondly might limit health costs. EbM provides a basis to choose the right procedures which are necessary for a valid diagnosis of illnesses and efficacious treatment of patients. As health toms; table 3). However, in terms of psychiatric co-morbidities analyzed showed a rather good discrimination in favor of depression (depression 0.75 > somatic symptoms of anxiety/depression = 0.66 > somatoform disorder = 0.53 > anxiety = 0.20).
The findings of the Clinical Global Impression Scale (CGI) rated by physicians as well as patients were in line with the findings of the ICD-10 and HAMD and have already been published just as the data for the Visual Analogue Scale (VAS) which correlated much weaker [18] .
Testing for sensitivity and specificity by increasing lower and upper cut-offs of the tested ICD-10 scores versus HAMD-17 scores is shown in figure 2 and 3 . The best trade-offs between specificity and sensitivity of the ICD-10 score were found at 10 points for the lower and 14 points for the upper cut-off (mild depression).
65.3% of the patients were correctly classified by the ICD-10 scale (table 4) . However, the severity of the disorder was overestimated in 11.4% and underestimated in 23.3% of the patients. The overall sensitivity and specificity was 76.7% and 88.6%. the difference between in-and outpatients might be more of scientific interest as they should not differ in depressive symptoms as such but in severity, which one would expect to be higher among inpatients. As a matter of fact, the current results can hardly be extrapolated on severely depressed patients.
The discussion about the use of the HAMD-17 [12, 13] shows a need not only for valid but also for widely accepted diagnostic instruments. The potential benefit of an ICD-10-derived symptom scale could be that it provides non-psychiatrists/GPs with an instrument that uses rather non-specialized termini which they are already trained to use as diagnostic criteria within the ICD-10 and which they ought to use for documentation and inter-physician communication anyway. Interestingly, a different ICD-10-derived scale, the ISR, has been developed and validated as a diagnostic tool for a variety of psychiatric disorders [7, 22] . For depression it is quite similar in terms of the 3 main symptoms of depression also covered by our scale. Thus, our scale (10 items) takes a kind of middle position in the number of depressive symptoms rated in the HAMD-17 (17 items) and the ISR (3 items). This underlines the need for evaluating an additional test instrument based on a generally accepted range of symptoms as well as being widely known and freely distributed and available. This should be a future goal not only for the rating of mental disorders [25] but also for daily practice in our Western medical system itself in terms of rational medical care and easily available evaluation instruments for diagnosis and treatment response.
Conclusion
The ICD-10 symptom scale examined in the current population was found to have fair correlation with the HAMD-17 as well as, in face of the limited variance of the patients' condition, acceptable sensitivity and specificity. However, a rigorous validation trial is necessary to corroborate these findings. costs seem to dominate not only political decisions in the medical system but also the choice of medical action (e.g. treatment, diagnosis), easily available diagnostic instruments become a precious value in the course of shared decisionmaking and treatment [14] .
Consequently, scales of diagnostic criteria that are already known to physicians, such as the ICD-10 criteria for depression which are generally used for documentation and referral, seem appropriate when they are valid in comparison with widely accepted scales such as the validated HAMD-17. To match both is highly rational and of great practical relevance. However, there is an ongoing discussion which depression scale could be seen as a gold standard [12, 13] . Additionally, the debate on inter-rater reliability accounts for the different valid questionnaires [6] and partly seems to be connected with clinical experience of physicians as such [8, 20] . This is a proof of the empirical knowledge on which medicine is based next to research evidence. Therefore, the idea to use a rating scale like the generated ICD-10-D seems reasonable in terms of the fact that physicians working in primary care are familiar with the ICD-10 itself. Moreover, the suitability of the ICD-10 criteria for depression have been examined before among GPs [16] and have been found to be sufficiently stable. Only the diagnostic stability over time is discussed although this seems arbitrary and related to other factors than validity itself [21] . ICD-10 criteria for depression also have been used in validation studies for other scales, like the self-rated Hopkins Symptom Checklist-10 (HSCL-10) [9] or the self-rated ICD-10 symptom rating (ISR) [7, 22] .
Nevertheless, there are limitations of this study. First of all, the study took place in a mixed physician group. One might argue that it would have been crucial to analyze inter-rater differences. On the one hand, we could not analyze this in the current preliminary study because patients were examined by one rater only. On the other hand, the ICD-10 criteria for depression have already shown to have a good inter-rater reliability in differentiating between depressed and non-depressed patients [23] . Secondly, the validation population is rather small and of limited variance of the patients' condition as can be seen in table 4. Noteworthy, it has been pointed out that making a diagnosis for a condition would depend both on the discriminatory value of the test and the prevalence of the disease in the population of interest [24] . Under this premise the preliminary validation data of the examined ICD-10 scale seem fair concerning correlation, sensitivity and specificity in the population tested, and for the feasibility purpose of the study. But one would have to admit that the findings need to be validated in a rigorous validation study. Thirdly, one might point out that our population consisted of inpatients only. But
